Holen Sie sich die Stockscreener-App
9.61
1.33%
-0.13
Handel nachbörslich:
9.61
Schlusskurs vom Vortag:
$9.74
Offen:
$9.84
24-Stunden-Volumen:
2.29M
Relative Volume:
1.43
Marktkapitalisierung:
$3.02B
Einnahmen:
$2.68B
Nettoeinkommen (Verlust:
$-184.45M
KGV:
-14.12
EPS:
-0.6805
Netto-Cashflow:
$229.23M
1W Leistung:
-2.14%
1M Leistung:
+1.69%
6M Leistung:
+11.48%
1J Leistung:
+8.83%
1-Tages-Spanne:
$9.57
$9.84
1-Wochen-Bereich:
$9.57
$10.34
52-Wochen-Spanne:
$6.685
$10.34
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
Firmenname
Amneal Pharmaceuticals Inc
Sektor
Telefon
908-947-3120
Adresse
400 Crossing Boulevard, 3rd Floor, Bridgewater
Vergleichen Sie AMRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
9.61 | 3.06B | 2.68B | -184.45M | 229.23M | -0.6805 |
|
ZTS
Zoetis Inc
|
146.93 | 65.35B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.09 | 47.75B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.40 | 41.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.38 | 21.43B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
403.68 | 18.00B | 2.99B | 1.21B | 1.13B | 25.06 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-06 | Eingeleitet | Goldman | Buy |
| 2025-02-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | Hochstufung | Goldman | Sell → Buy |
| 2020-12-14 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-12-14 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-27 | Eingeleitet | Goldman | Sell |
| 2020-05-12 | Hochstufung | Guggenheim | Sell → Neutral |
| 2019-12-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-11-07 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | Eingeleitet | Barclays | Equal Weight |
| 2019-05-21 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-03-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | Herabstufung | SunTrust | Buy → Hold |
| 2018-08-13 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-06-22 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Alle ansehen
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
Excessive Daytime Sleepiness Pipeline Insight 2025: Amneal’s FDA Approval of Sodium Oxybate Oral Solution, Novel Orexin Agonists, and Next-Generation Sleep-Wake Modulators Redefine Narcolepsy Care | D - Barchart.com
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
JPMorgan Chase & Co. Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $14.00 - MarketBeat
Jones Financial Companies Lllp Takes $1.73 Million Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Caxton Associates LLP Buys New Stake in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Excessive Daytime Sleepiness Pipeline Insight 2025: Amneal's - openPR.com
Woodline Partners LP Has $12.60 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Is Amneal Pharmaceuticals Inc in a long term uptrend2025 Year in Review & Stepwise Entry and Exit Trade Signals - خودرو بانک
AQR Capital Management LLC Buys 408,677 Shares of Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Acadian Asset Management LLC Has $21.76 Million Stock Holdings in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Aug Rallies: Can Amneal Pharmaceuticals Inc continue delivering strong returns2025 Momentum Check & Target Return Focused Picks - خودرو بانک
Analyst Downgrade: What are the future prospects of Amneal Pharmaceuticals Inc2025 Key Highlights & Weekly High Momentum Picks - خودرو بانک
Aug Big Picture: Does Amneal Pharmaceuticals Inc. have pricing powerGap Up & Weekly Top Performers Watchlists - خودرو بانک
Goldman Sachs Group Inc. Has $7.85 Million Holdings in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat
Aug Final Week: Is Amneal Pharmaceuticals Inc stock undervalued right nowQuarterly Profit Summary & Daily Growth Stock Investment Tips - خودرو بانک
Nasdaq Moves: Is Amneal Pharmaceuticals Inc forming a double bottomQuarterly Trade Report & Long-Term Capital Growth Strategies - خودرو بانک
Amneal secures FDA approval for sodium oxybate solution - World Pharmaceutical Frontiers
Aug Outlook: Can Amneal Pharmaceuticals Inc continue delivering strong returnsWeekly Profit Recap & Consistent Profit Alerts - خودرو بانک
Portfolio Update: Can Amneal Pharmaceuticals Inc continue delivering strong returnsEarnings Overview Summary & Risk Controlled Swing Alerts - خودرو بانک
Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 52-Week HighShould You Buy? - MarketBeat
Amneal receives FDA approval of treatment for narcoleptic sufferers - ROI-NJ
Ophthalmic Packaging Market Worth USD 23.65 Billion by 2034 | Towards Packaging - GlobeNewswire Inc.
Ieq Capital LLC Takes $288,000 Position in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat
Why Amneal (AMRX) Stock Is Up Today - Yahoo Finance
Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - Seeking Alpha
Amneal Pharmaceuticals Wins US FDA Approval for Generic Version of Narcolepsy Drug Xyrem - MarketScreener
Amneal receives US FDA approval of Sodium Oxybate Oral Solution - MarketScreener
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution - GlobeNewswire
150,000 Narcolepsy Patients Get New Option: Amneal's FDA-Approved Generic Breaks Single-Maker Market - Stock Titan
Amneal Pharmaceuticals: A Large, Diversified Clinical Portfolio That Keeps Growing (AMRX) - Seeking Alpha
Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by Raymond James Financial Inc. - MarketBeat
Northern Trust Corp Reduces Position in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat
684,116 Shares in AMNEAL PHARMACEUTICALS, INC. $AMRX Bought by Cubist Systematic Strategies LLC - MarketBeat
Anti-Parkinson's Drugs Global Markets to 2030 with AbbVie, Amneal Pharmaceuticals, Acadia Pharmaceut - PharmiWeb.com
Anti-Parkinson's Drugs Global Markets to 2030 with AbbVie, Amneal Pharmaceuticals, Acadia Pharmaceuticals, Supernus Pharmaceuticals and Teva Pharmaceutical DominatingResearchAndMarkets.com - Business Wire
Amneal Pharmaceuticals stock hits 52-week high at $9.79 By Investing.com - Investing.com Nigeria
Amneal Pharmaceuticals stock hits 52-week high at $9.79 - Investing.com
Is Amneal Pharmaceuticals Inc. a strong growth stockJuly 2025 Analyst Calls & Community Shared Stock Ideas - beatles.ru
AMNEAL PHARMACEUTICALS, INC. $AMRX Shares Bought by Dark Forest Capital Management LP - MarketBeat
Is Amneal Pharmaceuticals Inc.’s ROE strong enough2025 Analyst Calls & Free Real-Time Volume Trigger Notifications - beatles.ru
Should you wait for a breakout in Amneal Pharmaceuticals Inc.Bear Alert & Fast Moving Stock Trade Plans - Newser
Can machine learning forecast Amneal Pharmaceuticals Inc. recoveryPortfolio Value Summary & Stock Portfolio Risk Management - Newser
Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by Nantahala Capital Management LLC - MarketBeat
FDA Warns Amneal Pharmaceuticals Over Use of Contaminated IV Bags in Sterile Injectable Drug Production - geneonline.com
Amneal gets FDA nod for generic version of Risperdal Consta - MSN
Does Amneal Pharmaceuticals Inc. have pricing powerDollar Strength & Weekly Stock Breakout Alerts - خودرو بانک
Trexquant Investment LP Acquires 167,631 Shares of AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat
Should you avoid Amneal Pharmaceuticals Inc. stock right nowJuly 2025 Action & Low Risk Profit Maximizing Plans - خودرو بانک
Using R and stats models for Amneal Pharmaceuticals Inc. forecastingEarnings Risk Report & Advanced Technical Signal Analysis - Newser
What is the Moat Score of Amneal Pharmaceuticals Inc.2025 Biggest Moves & Reliable Entry Point Alerts - خودرو بانک
Why Amneal Pharmaceuticals Inc. is moving todayGap Down & Smart Money Movement Alerts - Newser
Finanzdaten der Amneal Pharmaceuticals Inc-Aktie (AMRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):